Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
publication
Title:
4-chlorobenzoyl chloride / 122-01-0
Author:
National Institute of Health Sciences / Kawasaki / Japan
Year:
2019
Bibliographic source:
https://dra4.nihs.go.jp/

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
4-chlorobenzoyl chloride
EC Number:
204-515-3
EC Name:
4-chlorobenzoyl chloride
Cas Number:
122-01-0
Molecular formula:
C7H4Cl2O
IUPAC Name:
4-chlorobenzoyl chloride
Constituent 2
Reference substance name:
p-Chlorbenzoylchlorid
IUPAC Name:
p-Chlorbenzoylchlorid

Test animals

Species:
rat
Strain:
Crj: CD(SD)

Administration / exposure

Route of administration:
oral: gavage
Duration of treatment / exposure:
Males: 42 days including 14 days pre-mating, mating, and thereafter 14 days (P)Females: 42–48
days including 14 days pre-mating, mating and gestation periods and the days until day 4 of lactation
No. of animals per sex per dose:
12

Results and discussion

Effect levels

Dose descriptor:
NOAEL
Effect level:
100 mg/kg bw/day (actual dose received)
Sex:
male/female

Applicant's summary and conclusion

Conclusions:
No observed adverse effect level (NOAEL) for repeated oral dosing was determined to be 100 mg/kg bw/
day in male and female rats. The available data do not support a classification as repeated dose organ toxic.